Department of Health Policy Archives
Aug. 16, 2018—While there has been much effort to control spending for individuals eligible for both Medicaid and Medicare in the United States, for the first time a team of Vanderbilt health policy researchers have analyzed spending trends for this population over a multiyear period in order to gain a much clearer understanding of exactly how much is being spent and by whom.
Aug. 9, 2018—As both drug prices and out-of-pocket expense for prescription medications continue to climb, a team of Health Policy experts at Vanderbilt University School of Medicine (VUSM) have received a grant to determine if these factors are causing older Americans enrolled in Medicare Part D for medication coverage to delay or never fill their prescriptions.
Jul. 26, 2018—A collaborative program across units at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt is changing the way nurses and doctors care for newborns diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS).
Jul. 26, 2018—No single approach will end the epidemic of fatal overdoses caused by addiction to opioid painkillers and heroin that is ravaging this country, the U.S. Assistant Secretary for Health, Adm. Brett Giroir, MD, warned Tuesday during a panel discussion in a packed lecture hall at Vanderbilt University Medical Center.
Jul. 19, 2018—Vanderbilt researchers have documented evidence that legalizing same-sex marriage has improved access to health care for gay men in a study released as a National Bureau of Economic Research working paper this week.
Jul. 12, 2018—In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.
May. 24, 2018—U.S. Surgeon General Jerome Adams, MD, MPH, visited Vanderbilt University Medical Center last week to speak at the spring Health Policy Grand Rounds at Langford Auditorium. The event was dedicated to combatting America’s opioid crisis, and Adams emphasized the importance of the overdose-reversal drug naloxone.
May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.
Apr. 19, 2018—“State Health Policy: Does Evidence Really Make a Difference” was the title of the spring Research into Policy and Practice Lecture, April 11 in Light Hall. The semi-annual lecture is sponsored by the Department of Health Policy.
Mar. 23, 2018—In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.